Who Doesn’t Love Mailbox Money?
How Does a Venture Capitalist Think?
Could The Struggling Shipping Industry Create a Banking Crash in Germany?
Here’s Why Rising Rates Are Good for Gold
Do People Really Believe Trump Will Bring a Million Manufacturing Jobs Back?
Steven Kriegsman of CytRx Corp talks to Equities.com about its top drug candidate Aldoxorubicin, which targets soft-tissue sarcoma.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).